Related references
Note: Only part of the references are listed.Reactivation of p53 function in synovial sarcoma cells by inhibition of p53-HDM2 interaction
Padraig D'Arcy et al.
CANCER LETTERS (2009)
Ras pathway activation in hepatocellular carcinoma and anti-tumoral effect of combined sorafenib and rapamycin in vivo
Pippa Newell et al.
JOURNAL OF HEPATOLOGY (2009)
Elevated MDM2 boosts the apoptotic activity of p53-MDM2 binding inhibitors by facilitating MDMX degradation
Mingxuan Xia et al.
CELL CYCLE (2008)
Experimental therapy of hepatoma with artemisinin and its derivatives:: In vitro and in vivo activity, chemosensitization, and mechanisms of action
Junmei Hou et al.
CLINICAL CANCER RESEARCH (2008)
p73 poses a barrier to malignant transformation by limiting anchorage-independent growth
Michaela Beitzinger et al.
EMBO JOURNAL (2008)
Mouse double minute antagonist Nutlin-3a enhances chemotherapy-induced apoptosis in cancer cells with mutant p53 by activating E2F1
G. Ambrosini et al.
ONCOGENE (2007)
Effects of artemisinin and its derivatives on growth inhibition and apoptosis of oral cancer cells
Woong Nam et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2007)
Nutlin3 blocks vascular endothelial growth factor induction by preventing the interaction between hypoxia inducible factor 1α and Hdm2
Gretchen A. LaRusch et al.
CANCER RESEARCH (2007)
MDM2 inhibitors for cancer therapy
Lyubomir T. Vassilev
TRENDS IN MOLECULAR MEDICINE (2007)
The role of p53 protein family in gastrointestinal malignancies
A. I. Zaika et al.
CELL DEATH AND DIFFERENTIATION (2006)
An shRNA barcode screen provides insight into cancer cell vulnerability to MDM2 inhibitors
TR Brummelkamp et al.
NATURE CHEMICAL BIOLOGY (2006)
Small-molecule MDM2 antagonists reveal aberrant p53 signaling in cancer: Implications for therapy
C Tovar et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Troglitazone inhibits tumor growth in hepatocellular carcinoma in vitro and in vivo
J Yu et al.
HEPATOLOGY (2006)
In vivo activation of the p53 pathway by small-molecule antagonists of MDM2
LT Vassilev et al.
SCIENCE (2004)
Expression of trkB in human neuroblastoma in relation to MYCN expression and retinoic acid treatment
A Edsjö et al.
LABORATORY INVESTIGATION (2003)
Tyrosine phosphorylation of Mdm2 by c-Abl: implications for p53 regulation
Z Goldberg et al.
EMBO JOURNAL (2002)
p63 and p73 are required for p53-dependent apoptosis in response to DNA damage
ER Flores et al.
NATURE (2002)
A phosphatidylinositol 3-kinase/Akt pathway promotes translocation of Mdm2 from the cytoplasm to the nucleus
LD Mayo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Share Paper
